- Home
- VYX vs SRPT Comparison
VYX vs SRPT Comparison
Compare VYX & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYX
- SRPT
- Stock Information
- Founded
- VYX 1881
- SRPT 1980
- Country
- VYX United States
- SRPT United States
- Employees
- VYX N/A
- SRPT N/A
- Industry
- VYX
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- VYX
- SRPT Health Care
- Exchange
- VYX Nasdaq
- SRPT Nasdaq
- Market Cap
- VYX 1.8B
- SRPT 1.7B
- IPO Year
- VYX N/A
- SRPT 1997
- Fundamental
- Price
- VYX $14.38
- SRPT $11.93
- Analyst Decision
- VYX Strong Buy
- SRPT Hold
- Analyst Count
- VYX 5
- SRPT 28
- Target Price
- VYX $14.40
- SRPT $48.42
- AVG Volume (30 Days)
- VYX 2.0M
- SRPT 13.9M
- Earning Date
- VYX 08-07-2025
- SRPT 08-06-2025
- Dividend Yield
- VYX N/A
- SRPT N/A
- EPS Growth
- VYX N/A
- SRPT N/A
- EPS
- VYX 6.72
- SRPT N/A
- Revenue
- VYX $2,733,000,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- VYX N/A
- SRPT $19.93
- Revenue Next Year
- VYX N/A
- SRPT N/A
- P/E Ratio
- VYX $2.05
- SRPT N/A
- Revenue Growth
- VYX N/A
- SRPT 59.15
- 52 Week Low
- VYX $7.55
- SRPT $10.42
- 52 Week High
- VYX $15.34
- SRPT $150.48
- Technical
- Relative Strength Index (RSI)
- VYX 71.41
- SRPT 28.15
- Support Level
- VYX $13.91
- SRPT $10.42
- Resistance Level
- VYX $14.65
- SRPT $14.54
- Average True Range (ATR)
- VYX 0.45
- SRPT 1.90
- MACD
- VYX 0.02
- SRPT 0.13
- Stochastic Oscillator
- VYX 82.14
- SRPT 12.14
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.